loadpatents
name:-0.012814998626709
name:-0.011847019195557
name:-0.00088906288146973
Lin; Jiandie Patent Filings

Lin; Jiandie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lin; Jiandie.The latest application filed is for "methods of treating metabolic disorders".

Company Profile
0.10.9
  • Lin; Jiandie - Ann Arbor MI
  • Lin; Jiandie - Brookline MA
  • Lin; Jiandie - Evanston IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods of treating metabolic disorders
Grant 9,878,010 - Lin , et al. January 30, 2
2018-01-30
Methods Of Treating Metabolic Disorders
App 20160279201 - Lin; Jiandie ;   et al.
2016-09-29
Compositions and methods for modulating PGC-1.beta. to treat lipid-related diseases and disorders
Grant 8,889,639 - Spiegelman , et al. November 18, 2
2014-11-18
PGC-1.beta., a novel PGC-1 homologue and uses therefor
Grant 8,445,233 - Spiegelman , et al. May 21, 2
2013-05-21
Compositions and Methods for Modulating PGC-1Alpha to Treat Neurological Diseases and Disorders
App 20120167240 - Lin; Jiandie ;   et al.
2012-06-28
Pgc-1 , A Novel Pgc-1 Homologue And Uses Therefor
App 20120094293 - SPIEGELMAN; BRUCE M. ;   et al.
2012-04-19
PGC-1.beta., PGC-1 homologue and uses therefor
Grant 8,105,774 - Spiegelman , et al. January 31, 2
2012-01-31
Compositions and methods for modulating PGC-1.alpha. to treat huntington's disease
Grant 7,947,652 - Lin , et al. May 24, 2
2011-05-24
Compositions and Methods for Modulating Pgc-1Alpha to Treat Neurological Diseases and Disorders
App 20090005314 - Lin; Jiandie ;   et al.
2009-01-01
PGC-1Beta, A Novel PGC-1 Homologue and Uses Therefor
App 20080261224 - Spiegelman; Bruce M. ;   et al.
2008-10-23
Compositions and Methods For Modulating Pgc-1Beta to Treat Lipid-Related Diseases and Disorders
App 20080206232 - Spiegelman; Bruce M. ;   et al.
2008-08-28
PGC-1.beta., a novel PGC-1 homologue and uses therefor
Grant 7,354,738 - Spiegelman , et al. April 8, 2
2008-04-08
PGC-1beta, a novel PGC-1 homologue and uses therefor
App 20070009933 - Spiegelman; Bruce M. ;   et al.
2007-01-11
PGC-1.beta., a novel PGC-1 homologue and uses therefor
Grant 7,091,006 - Spiegelman , et al. August 15, 2
2006-08-15
Methods and composition for modulating type I muscle formation using pgc-1 alpha
App 20060035849 - Spiegelman; BruceM ;   et al.
2006-02-16
PGC-1beta, a novel PGC-1 homologue and uses therefor
App 20030124598 - Spiegelman, Bruce M. ;   et al.
2003-07-03
Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells
Grant 6,261,841 - Cohen , et al. July 17, 2
2001-07-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed